
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.37 | 1.37 | 0.00 |
Shares | 98.63 | 98.63 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.29 | 16.08 |
Price to Book | 2.67 | 2.50 |
Price to Sales | 2.10 | 1.72 |
Price to Cash Flow | 11.77 | 10.49 |
Dividend Yield | 2.14 | 2.49 |
5 Years Earnings Growth | 14.92 | 9.31 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 20.99 | 21.45 |
Healthcare | 20.71 | 14.67 |
Industrials | 16.01 | 11.92 |
Technology | 11.56 | 13.21 |
Consumer Cyclical | 9.33 | 7.07 |
Energy | 6.90 | 7.39 |
Communication Services | 6.33 | 5.85 |
Basic Materials | 3.14 | 3.38 |
Real Estate | 3.06 | 3.38 |
Consumer Defensive | 1.96 | 8.21 |
Number of long holdings: 51
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
JPMorgan | US46625H1005 | 4.63 | 290.49 | -1.25% | |
AbbVie | US00287Y1091 | 3.77 | 206.69 | +0.98% | |
Fiserv | US3377381088 | 3.35 | 136.70 | +1.55% | |
Abbott Labs | US0028241000 | 3.08 | 131.75 | +1.91% | |
Parker-Hannifin | US7010941042 | 3.07 | 729.96 | -2.06% | |
Goldman Sachs | US38141G1040 | 2.90 | 730.72 | -2.21% | |
Exxon Mobil | US30231G1022 | 2.75 | 106.49 | -0.83% | |
Honeywell | US4385161066 | 2.67 | 216.77 | -0.66% | |
Meta Platforms | US30303M1027 | 2.66 | 785.23 | +0.40% | |
Boston Scientific | US1011371077 | 2.62 | 103.17 | -0.94% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Homestead Growth | 428.36M | 10.44 | 22.87 | 15.65 | ||
Homestead Stock Index | 285.47M | -5.04 | 11.66 | 11.74 | ||
Homestead Small Company Stock | 212.78M | -4.93 | 2.26 | 5.07 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review